BRIEF-Trovagene Inc updates on clinical trial for PCM-075 | Reuters

Reuters| Mon Nov 13 04:47:59 EST 2017
Nov 13 (Reuters) - Trovagene Inc: * Trovagene announces activation of first clinical trial site in phase 1B/2 acute myeloid leukemia (AML) trial for PCM-075 * Trovagene Inc - ‍activation of its clinical trial site for its phase 1B/2 multicenter trial of PCM-075 in patients with AML​ * Trovagene Inc - ‍trial will enroll subjects in phase 1B who have relapsed or have resistant disease to no more than three prior regimens​ Source text for Eikon: Further company coverage:

Related Articles

Nov 13 (Reuters) - Trovagene Inc: * Trovagene announces activation of first clinical trial site in phase 1B/2 acute myeloid leukemia (AML) trial for PCM-075 * Trovagene Inc - ‍acti....
Reuters| Mon Nov 13 04:47:59 EST 2017
Nov 2 (Reuters) - Biogen Inc: * Biogen presents new data from long-term extension of phase 1b study of investigational alzheimer’s disease treatment aducanumab * Biogen Inc - ‍as o....
Reuters| Thu Nov 02 05:33:01 EDT 2017
Nov 6 (Reuters) - Reata Pharmaceuticals Inc: * Reata provides update on bardoxolone methyl from the american society of nephrology kidney week meeting * Reata pharmaceuticals - act....
Reuters| Mon Nov 06 04:15:44 EST 2017
Nov 6 (Reuters) - Anaptysbio Inc * Anaptysbio reports positive anb019 top-line phase 1 clinical trial results * Top-line data demonstrated favorable safety, pharmacokinetics and ph....
Reuters| Mon Nov 06 13:15:33 EST 2017
Nov 8 (Reuters) - Synlogic Inc * Synlogic reports positive top-line phase 1 data demonstrating safety and tolerability and proof of mechanism in healthy volunteers for synb1020, a ....
Reuters| Wed Nov 08 04:55:30 EST 2017
Nov 7 (Reuters) - Kala Pharmaceuticals Inc * Kala Pharmaceuticals reports third quarter 2017 financial results and provides business update * Q3 loss per share $0.56 * Kala Pharmac....
Reuters| Tue Nov 07 04:03:26 EST 2017
Nov 7 (Reuters) - Novan Inc: * Novan Inc -‍agreed to business structure to enable development of SB204 via 3rd party financing, 3rd party execution of additional Phase 3 pivotal tr....
Reuters| Tue Nov 07 04:39:29 EST 2017
Nov 7 (Reuters) - Novan Inc: * Novan Inc -‍agreed to business structure to enable development of SB204 via 3rd party financing, 3rd party execution of additional Phase 3 pivotal tr....
Reuters| Tue Nov 07 04:59:48 EST 2017
Nov 9 (Reuters) - Five Prime Therapeutics Inc * Bristol-Myers Squibb and Five Prime present phase 1a/1b data evaluating Cabiralizumab (anti-csf-1 receptor antibody) with Opdivo (ni....
Reuters| Thu Nov 09 04:51:55 EST 2017
Nov 2 (Reuters) - Oncomed Pharmaceuticals Inc * Oncomed announces third quarter 2017 financial results and operational highlights * Q3 loss per share $0.28 * Q3 revenue $5.1 millio....
Reuters| Thu Nov 02 14:39:52 EDT 2017
Nov 10 (Reuters) - Fate Therapeutics Inc * Fate Therapeutics announces initial clinical data from ongoing first-in-human voyage study of Fate-NK100 for relapsed / refractory acute ....
Reuters| Fri Nov 10 04:31:45 EST 2017
Nov 6 (Reuters) - Cellectis SA * FDA lifts clinical hold on cellectis phase 1 clinical trials with UCART123 in AML and BPDCN * Says ‍working with investigators and clinical sites t....
Reuters| Mon Nov 06 16:03:27 EST 2017
Nov 1 (Reuters) - Momenta Pharmaceuticals Inc * Momenta And Mylan report initial results from phase 1 clinical trial for M834, a proposed biosimilar of Orencia® (abatacept) * Mylan....
Reuters| Wed Nov 01 05:56:38 EDT 2017
Nov 15 (Reuters) - Ultragenyx Pharmaceutical Inc: * ULTRAGENYX ANNOUNCES FDA APPROVAL OF MEPSEVII™ (VESTRONIDASE ALFA), THE FIRST THERAPY FOR PROGRESSIVE AND DEBILITATING RARE GENE....
Reuters| Wed Nov 15 10:03:49 EST 2017
Nov 7 (Reuters) - Chemocentryx Inc: * Chemocentryx reports third quarter 2017 financial results and recent highlights * Q3 revenue $9.0 million versus I/B/E/S view $9 million * Che....
Reuters| Tue Nov 07 13:11:42 EST 2017
Nov 14 (Reuters) - Nanovibronix Inc * Nanovibronix to commence trial of anti-aging device in collaboration with a global cosmetics company * Execution of collaborative agreement to....
Reuters| Tue Nov 14 04:31:42 EST 2017
Nov 9 (Reuters) - Idera Pharmaceuticals Inc * Idera Pharmaceuticals Inc presents positive translational and clinical data update from ongoing IMO-2125 development program at the 20....
Reuters| Thu Nov 09 04:23:34 EST 2017
Oct 31 (Reuters) - Stemline Therapeutics Inc * Stemline Therapeutics Inc - ‍phase 2 trial of SL-401 in Blastic Plasmacytoid Dendritic Cell Neoplasm has met its primary endpoint​ * ....
Reuters| Tue Oct 31 05:20:05 EDT 2017
Nov 15 (Reuters) - Spring Bank Pharmaceuticals Inc * Spring Bank Pharmaceuticals announces positive top-line results from the second cohort of part A of the phase 2 achieve trial *....
Reuters| Wed Nov 15 13:03:34 EST 2017
Nov 9 (Reuters) - Catabasis Pharmaceuticals Inc * Catabasis Pharmaceuticals reports third quarter 2017 financial results and reviews business progress * Q3 loss per share $0.31 * Q....
Reuters| Thu Nov 09 13:40:32 EST 2017
Nov 14 (Reuters) - Rhythm Pharmaceuticals Inc * Rhythm Pharmaceuticals reports third quarter 2017 financial results * Q3 loss per share $1.78 * Q3 earnings per share view $-0.40 --....
Reuters| Tue Nov 14 04:43:43 EST 2017
Nov 1 (Reuters) - NII Holdings Inc * NII Holdings announces signing of amendments to Nextel Brazil loan agreements * NII Holdings Inc - its unit ‍signed amendments to its loan agre....
Reuters| Wed Nov 01 05:07:50 EDT 2017
Nov 15 (Reuters) - Tarena International Inc * Tarena International, Inc. signs strategic partnership agreement with MYbank * Tarena International - ‍signed strategic partnership ag....
Reuters| Wed Nov 15 04:07:20 EST 2017
Nov 14 (Reuters) - Zynerba Pharmaceuticals Inc * Zynerba Pharmaceuticals reports third quarter 2017 financial results and operational highlights * Q3 loss per share $0.63 * Q3 earn....
Reuters| Tue Nov 14 04:11:45 EST 2017
Nov 13 (Reuters) - Neuralstem Inc * Neuralstem reports third quarter 2017 fiscal results and provides clinical and business update * Q3 loss per share $0.01 * Neuralstem - ‍expect ....
Reuters| Mon Nov 13 04:11:58 EST 2017
Nov 2 (Reuters) - Tetraphase Pharmaceuticals Inc * Tetraphase pharmaceuticals reports third quarter 2017 financial results and highlights recent clinical and corporate achievements....
Reuters| Thu Nov 02 05:40:58 EDT 2017
Nov 7 (Reuters) - Alder Biopharmaceuticals Inc * Alder biopharmaceuticals announces third quarter 2017 financial and operating results * Q3 loss per share $0.92 * Q3 earnings per s....
Reuters| Tue Nov 07 13:29:52 EST 2017
Nov 9 (Reuters) - Nabriva Therapeutics Plc * Nabriva Therapeutics reports third quarter 2017 financial results and recent corporate highlights * Q3 loss per share $0.79 * Q3 earnin....
Reuters| Thu Nov 09 04:15:40 EST 2017
Nov 14 (Reuters) - Appliance Recycling Centers of America Inc * Appliance Recycling Centers of America announces third quarter 2017 financial results * Q3 revenue $25.5 million * Q....
Reuters| Tue Nov 14 04:59:32 EST 2017
Nov 7 (Reuters) - Aytu Bioscience Inc: * Aytu Bioscience receives market approval from the Australian therapeutic goods administration for the Mioxsys® system for male infertility ....
Reuters| Tue Nov 07 04:39:29 EST 2017
Nov 7 (Reuters) - Aytu Bioscience Inc: * Aytu Bioscience receives market approval from the Australian therapeutic goods administration for the Mioxsys® system for male infertility ....
Reuters| Tue Nov 07 04:59:48 EST 2017
Nov 8 (Reuters) - Agrofresh Solutions Inc * Agrofresh extends post-harvest leadership into citrus with acquisition of Tecnidex * Agrofresh Solutions Inc - ‍purchase is immediately ....
Reuters| Wed Nov 08 04:03:01 EST 2017
Nov 13 (Reuters) - Qudian Inc - * Qudian inc. Reports third quarter 2017 unaudited financial results * Q3 adjusted earnings per share rmb 2.24 * Q3 earnings per share rmb 2.20 * Q3....
Reuters| Mon Nov 13 01:19:34 EST 2017
Nov 6 (Reuters) - Esperion Therapeutics Inc * Esperion announces initiation of pivotal late stage study for the bempedoic acid / ezetimibe combination pill * Esperion Therapeutics ....
Reuters| Mon Nov 06 13:19:36 EST 2017
Nov 2 (Reuters) - Ashford Hospitality Trust Inc * Ashford Trust reports third quarter 2017 results * Ashford Hospitality Trust Inc qtrly ‍shr $0.40​ * Ashford Hospitality Trust Inc....
Reuters| Thu Nov 02 14:09:04 EDT 2017
Nov 8 (Reuters) - Macrogenics Inc * Macrogenics provides update on corporate progress and third quarter 2017 financial results * Qtrly ‍total revenues $1.7 million versus $3.3 mill....
Reuters| Wed Nov 08 13:03:30 EST 2017
Nov 2 (Reuters) - Kinsale Capital Group Inc: * Kinsale Capital Group reports 2017 third quarter results * Q3 earnings per share $0.20 * Q3 earnings per share view $0.18 -- Thomson ....
Reuters| Thu Nov 02 14:09:04 EDT 2017
Nov 13 (Reuters) - Reata Pharmaceuticals Inc * Reata Pharmaceuticals Inc announces third quarter 2017 financial and operating results * Q3 loss per share $0.50 * Q3 earnings per sh....
Reuters| Mon Nov 13 04:07:39 EST 2017

You May Also Like To Read

Oct 30 (Reuters) - Johnson & Johnson * Janssen Inc. announces Imbruvica® (ibrutinib) as the first approved treatment for chronic graft-versus-host disease (CGVHD) granted by He....
Reuters| Mon Oct 30 05:03:24 EDT 2017
Nov 13 (Reuters) - Clementia Pharmaceuticals Inc: * Clementia Pharmaceuticals Inc - qtrly loss per share ‍$1.83​ * Clementia Pharmaceuticals Inc- ‍as of September 30, 2017, had cas....
Reuters| Mon Nov 13 04:47:59 EST 2017
Nov 7 (Reuters) - Galectin Therapeutics Inc * Galectin Therapeutics Inc - Qtrly loss per share $0.13‍​ * Galectin Therapeutics Inc - ‍Top line results of NASH-CX phase 2B clinical ....
Reuters| Tue Nov 07 04:35:40 EST 2017
Nov 7 (Reuters) - Galectin Therapeutics Inc * Galectin Therapeutics Inc - Qtrly loss per share $0.13‍​ * Galectin Therapeutics Inc - ‍Top line results of NASH-CX phase 2B clinical ....
Reuters| Tue Nov 07 04:59:49 EST 2017
Nov 1 (Reuters) - Resverlogix Corp * Resverlogix announces fifth positive recommendation from Data Safety Monitoring Board for phase 3 study of Apabetalone * Resverlogix - ‍indepen....
Reuters| Wed Nov 01 06:00:53 EDT 2017
Nov 13 (Reuters) - Fibrocell Science Inc * Fibrocell reports third quarter 2017 financial results and recent highlights * Company believes that its cash and cash equivalents at Sep....
Reuters| Mon Nov 13 04:47:59 EST 2017
Nov 16 (Reuters) - KemPharm Inc- * KemPharm completes successful end-of-Phase 2 meeting on KP415 with FDA * KemPharm - held meeting to discuss status of proposed clinical, non-clin....
Reuters| Thu Nov 16 04:03:07 EST 2017
Nov 1 (Reuters) - Intercept Pharmaceuticals Inc * Intercept Pharmaceuticals reports third quarter 2017 financial results and provides business update * Intercept - ‍non-GAAP adjust....
Reuters| Wed Nov 01 05:07:50 EDT 2017
Nov 8 (Reuters) - Sun Life Financial Inc * Sun Life Financial reports third quarter 2017 results * Sun Life Financial Inc - qtrly ‍reported EPS $1.32​ * Sun Life Financial Inc - qt....
Reuters| Wed Nov 08 13:32:13 EST 2017
Nov 6 (Reuters) - Premier Inc * Premier Inc - ‍OU Medical Center has signed multi-year agreement with Premier Inc to access performance improvement technology solutions and service....
Reuters| Mon Nov 06 07:03:31 EST 2017
Nov 16 (Reuters) - Altius Minerals Corp * Altius Resources Inc. acquires securities of Wolfden Resources Corporation * ‍Altius Resources Inc - on Nov 15, 2017 co purchased 14.2 mil....
Reuters| Thu Nov 16 13:41:40 EST 2017
Nov 16 (Reuters) - Griffon Corp * Berry global group, inc. Announces agreement to acquire the clopay plastic products company, inc., from griffon corporation * Berry global group i....
Reuters| Thu Nov 16 04:35:33 EST 2017
Nov 9 (Reuters) - IBI Group Inc * IBI Group Inc announces third quarter 2017 financial results * Qtrly earnings per share $0.15‍​ * IBI Group Inc says ‍revenue increased to $89.8 m....
Reuters| Thu Nov 09 13:56:45 EST 2017
Nov 10 (Reuters) - GAIN Capital Holdings Inc * GAIN Capital Holdings Inc announces monthly metrics for October 2017 * GAIN Capital Holdings Inc - ‍october 2017 retail segment OTC t....
Reuters| Fri Nov 10 04:59:23 EST 2017
Nov 10 (Reuters) - Gluskin Sheff + Associates Inc: * Gluskin Sheff + Associates Inc announces first quarter fiscal 2018 results * Q1 revenue C$28.6 million * Gluskin Sheff + Associ....
Reuters| Fri Nov 10 13:39:34 EST 2017
Nov 15 (Reuters) - Prudential Bancorp Inc * Prudential Bancorp Inc announces declaration of quarterly cash dividend plus special nonrecurring dividend * Prudential Bancorp Inc - ‍d....
Reuters| Wed Nov 15 13:03:34 EST 2017
Nov 7 (Reuters) - Spark Therapeutics Inc * Spark Therapeutics and Pfizer amend license agreement for investigational SPK-9001 in hemophilia B * Spark Therapeutics Inc - Co transfer....
Reuters| Tue Nov 07 04:07:44 EST 2017
Nov 16 (Reuters) - Oncolytics Biotech Inc * Oncolytics Biotech® Inc. and Adlai Nortye enter into $86.6 million regional licensing agreement for Reolysin® * Oncolytics Biotech Inc -....
Reuters| Thu Nov 16 13:37:41 EST 2017
Nov 13 (Reuters) - Redhill Biopharma Ltd * Redhill Biopharma reports 2017 third quarter financial results * Q3 revenue $1.5 million * Redhill Biopharma Ltd - ‍decrease quarterly ca....
Reuters| Mon Nov 13 04:11:58 EST 2017